Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rocket Doctor AIAIRDF +7.59%27 EBIT per Share is $-0.15 as of Mar. 2026. GuruFocus rates AIRDF with a GF Score™ of 27/100. The stock has 7 warning signs investors should review. Among 524 Healthcare Providers & Services companies, Rocket Doctor AI ranks better than 74.24% on this metric.
Rocket Doctor AI's EBIT per Share for the
three
months ended in Mar. 2026 was $-0.04.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.15.
During the past 3 years, the average EBIT per Share Growth Rate was 32.90% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 33.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Rocket Doctor AI's EBIT per Share or its related term are showing as below:
AIRDF'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -79.9 Med: 31 Max: 59.9
Current: 32.9
During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of Rocket Doctor AI was 59.90% per year. The lowest was -79.90% per year. And the median was 31.00% per year.
AIRDF's 3-Year EBIT Growth Rate is ranked better than 74.24% of 524
companies
in the Healthcare Providers & Services industry
Industry Median: 11.95
vs AIRDF: 32.90
Rocket Doctor AI (OTCPK:AIRDF) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Rocket Doctor AI EBIT per Share Related Terms
Rocket Doctor AI EBIT per Share Historical Data
* Premium members only.
The historical data trend for Rocket Doctor AI's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.15
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rocket Doctor AI (AIRDF) has a EBIT per Share of $-0.15 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Rocket Doctor AI and its competitors. According to the industry distribution chart, Rocket Doctor AI ranks #135 out of 524 companies in the Healthcare Providers & Services industry, placing it in the top 25.8%.
Is Rocket Doctor AI's EBIT per Share too high?
Rocket Doctor AI's current EBIT per Share is $-0.15. Based on the distribution chart, Rocket Doctor AI ranks #135 out of 524 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Rocket Doctor AI has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Rocket Doctor AI's EBIT per Share compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Rocket Doctor AI ranks #135 out of 524 companies for EBIT per Share. This puts Rocket Doctor AI in the upper half of its industry. The industry median EBIT per Share is 11.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.95, based on 524 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Rocket Doctor AI and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rocket Doctor AI's current EBIT per Share is $-0.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rocket Doctor AI stock overvalued right now?
Rocket Doctor AI (AIRDF) has a current EBIT per Share of $-0.15. The current EBIT per Share is $-0.15. Rocket Doctor AI's overall GF Score™ is 27/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Rocket Doctor AI (AIRDF), the current EBIT per Share is $-0.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Rocket Doctor AI Inc delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company's proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians world-wide. Alongside the GLM and its AI-powered digital health platform and marketplace. The group empowers over 300 MDs to provide care to more than 700,000 patients. Its proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care.
27GF Score
Get the complete analysis for AIRDF
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AIRDF has been successfully added to your 
